News from NYU Langone Health
Not Born Equal: Preemie Babies Fall Into 3 Risk Categories. (HealthDay)
HealthDay (8/14) A new study finds that prematurely born babies “tend to fall into three risk categories, with about one in five (20%) scoring above average on standard cognitive tests,” with lead researcher Iris Menu, PhD, postdoctoral fellow, saying, “Our study dispels the notion that every preterm child is born with cognitive and behavioral deficits.” Moriah Thomason, PhD, the Barakett Associate Professor of Child and Adult Psychiatry, Department of Child and Adult Psychiatry, associate professor, Department of Population Health, vice chair, Research, Department of Child and Adolescent Psychiatry, said, “Our work highlights the complexity of preterm birth, and promises to improve treatment for each individual child.”
A Clear Path Forward. (Opthalmology Times)
Opthalmology Times (8/13) Kathryn A. Colby, MD, PhD, the Elisabeth J. Cohen, M.D. Professor of Ophthalmology, Department of Ophthalmology, chair, Department of Ophthalmology, writes in her article discussing fuchs endothelial corneal dystrophy (FECD), “A better understanding of the biology of FECD will aid in developing effective treatments and preventive strategies,” with medical therapy being “likely within 10 to 20 years.”
Resected Melanoma: Subsequent Systemic Therapy After Recurrence On Adjuvant Nivolumab. (ASCO Post)
ASCO Post (8/13) “In an analysis from the phase III CheckMate 238 trial reported in the Journal of Clinical Oncology, Jeffrey S. Weber, MD, PhD, the Laura and Isaac Perlmutter Professor of Oncology, Department of Medicine, Division of Hematology and Medical Oncology, Perlmutter Cancer Center, “and colleagues found that progression-free and overall survival were improved with subsequent systemic therapy following late vs early recurrence with adjuvant nivolumab in patients with resected stage IIIB–C or IV melanoma.”
FDA Rejection Of MDMA-Assisted Therapy Rattles Advocates But Doesn’t Spell End Of Psychedelics In Medicine, Experts Say. (CNN)
CNN (8/13) “The FDA has a high bar for approval – and for good reason, said Michael Bogenschutz, MD, professor, Department of Psychiatry,” who said, “I think we just need to take a deep breath and be patient and let the data accumulate to show more definitively, one way or the other, whether, in this particular case, MDMA can become a bona fide medical treatment for PTSD.”
Research Shows The Ages Our Metabolism Undergoes Massive Rapid Changes. (NBC News)
NBC News (8/14) “Researchers have found that molecules and microorganisms both inside and outside our bodies are going through dramatic changes, first at about age 44 and then again when we hit 60,” with Josef Coresh, MD, PhD, the Terry and Mel Karmazin Professor of Population Health, Department of Population Health, professor, Department of Medicine comparing “the new findings to the invention of the microscope,” saying, “The beauty of this type of paper is the level of detail we can see in molecular changes.”
Doctors Accused Of Spreading Misinformation Lose Certifications. (Washington Post)
The Washington Post (8/13) The American Board of Internal Medicine revoked the certifications of Pierre Kory and Paul Marik for promoting ivermectin as a covid treatment despite its ineffectiveness, impacting their ability to practice at major hospitals and academic institutions; Jonathan E. Howard, MD, associate professor, Departments of Neurology, and Psychiatry, remarked, “It’s a little bit ‘too little, too late,’” criticizing the delay in consequences for their misinformation, which has had potentially catastrophic effects.
GLP-1 Agonists May Help Curb Tobacco Cravings. (KCBS-TV Los Angeles)
KCBS-TV (8/14) New research suggests that popular weight-loss drugs like Wegovy may reduce more than just appetite, with Jonathan D. LaPook, MD, the Mebane Professor of Gastroenterology, Department of Medicine, Division of Gastroenterology and Hepatology, professor, Department of Population Health explaining that patients with type two diabetes and tobacco use disorder experienced a reduced desire to smoke when using semaglutide, the drug found in Ozempic and Wegovy. Michael A. Weintraub, MD, clinical assistant professor, Department of Medicine, the Holman Division of Endocrinology, Diabetes & Metabolism prescribes GLP-1 agonists for type two diabetes and obesity, and emphasized the importance of using FDA-approved medications for smoking cessation and alcohol use disorder first.
How Parents Can Cope With Empty Nest Syndrome. (WPIX-TV New York)
WPIX-TV New York (8/13) Thea Gallagher, PsyD, clinical associate professor, Department of Psychiatry, “joins PIX11 to share tips on how parents can cope with empty nest syndrome as their children leave home.”
News from NYU Langone Hospital – Brooklyn
Pain Relief For IUD Insertion: CDC Updates Its Recommended Guidance To Help Women. (Fox News)
Fox News (8/13) The U.S. Centers for Disease Control and Prevention (CDC) is recommending pain management protocols for intrauterine device (IUD) insertion, with Meleen Chuang, MD, clinical associate professor, Department of Obstetrics and Gynecology, chief, Obstetrics and Gynecology, Family Health Centers, NYU Langone Hospital—Brooklyn, stating, “It is welcoming to see the CDC reflect the updates for guidance in accordance to our care delivery.”
News from NYU Langone Hospital – Long Island
Billion-Dollar Building Babies: Projects Set To Redefine Nassau And Suffolk Counties. (Long Island (NY) Press)
The Long Island (NY) Press (8/13) NYU Langone Health, which operates NYU Langone Hospital – Long Island in Mineola and about 70 other Long Island sites, is planning to construct a medical center exceeding $3 billion on the grounds of Nassau Community College, following the recent opening of a $170 million ambulatory center in Garden City; other notable developments in the region include Mount Sinai South Nassau’s new facility in Long Beach and Stony Brook Medicine’s Advanced Specialty Care at Smith Haven Mall in Lake Grove.
